Skip to content

Novavax NVAX Debt-to-equity

Debt-to-equity at other companies

Moderna logo
ModernaMRNA
0.2×+0.1×
Roivant Sciences logo
Roivant SciencesROIV
0.0×
Merck & Co. logo
Merck & Co.MRK
1.1×+0.3×
Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
0.0×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
0.1×0.0×
ALN
Alnylam PharmaceuticalsALNY
0.2×-0.4×

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+28.6%
Enterprise value$1.53B+68.6%
P/S2.5×+1.5×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Current ratio2.5×+0.4×

Where this comes from

Calculated from Novavax’s reported figures.

Based on the most recent quarter.

The official record: Novavax’s 10-Q, filed August 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about Novavax's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's debt-to-equity?
Novavax (NVAX) reported debt-to-equity of 1.5× in Q2 2025.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.